Dean Koh

The funds will be used by the Seqster to accelerate the adoption of their interoperability technology for clinical trials, patient engagement and outcomes.  

A new study, conducted by Korean academic hospitals and Lunit, a medical AI company specializing in developing AI solutions for radiology and oncology, demonstrated the benefits of AI-aided breast cancer detection from mammography images.

Last week, Victoria-based Melbourne Pathology became the latest pathology provider to upload reports to My Health Record (MHR).

The Australian Digital Health Agency (ADHA) today announced the launch of a new professional development program to identify the necessary digital health capabilities for nurses and midwives to further improve the quality, safety and efficiency of care.

Japanese giant Sumitomo Dainippon Pharma and Oxford-headquartered AI-driven drug discovery company Exscientia yesterday announced that they have created a new compound which is in the process of entering human clinical trials in Japan.

Nearing the first anniversary of the My Health Record (MHR) collection deadline on 31st January 2020, the Australian Digital Health Agency (ADHA) has announced that the total number of MHRs with information has reached 12.

These services include digital diagnostic pathology, access to proton therapy information, teaching surgery, an AI-enabled care for in-patients and an autonomous robot for operating rooms.

ADHA has been working with industry and governments over a number of years to achieve interoperable secure messaging across different systems.

Better health information systems that allow every Thai to access their personal health information, including diabetes risk and screening records, could contribute to reducing unmet need.

“This is a big step forward in personalizing cancer treatment and ensuring better patient outcomes,” said Professor Lim Chwee Teck, Mechanobiology Institute, NUS Biomedical Engineering.